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The addition of 5-azacytidine to erythroleukemic ells which were induced to differentiate with DMSO or 
BA altered the expression of the hemoglobins. After the addition of 5-azacytidine there was an increase 
in hemoglobin synthesis especially in the embryonic E2 band. The ,&globin increased in synthesis after 
S-azacytidine treatment. The level of hemoglobin synthesis in DMSO-induced cells is less than BA-induced 
cells while the effect of the 5-azacytidine stimulation was greater with DMSO induction than with BA 
induction. 
Hemoglobin Globin Murine 
Dlyferentiation 
1. INTRODUCTION 
In humans, fetal hemoglobin genes are 
undermethylated and expressed in fetal life while 
they are methylated and unexpressed in adult life 
[l]. It has been shown with tissue culture cells that 
the addition of 5-azacytidine to cells growing in 
tissue culture can undermethylate newly- 
synthesized DNA resulting in altered gene expres- 
sion [2-51. In vivo studies on anemic baboons 
showed that 5azacytidine increased the produc- 
tion of fetal hemoglobin [6], while studies on 
human patients suffering from ,&thalassemia or 
sickle cell anemia showed an increase in the syn- 
thesis of y-globin and e-globin after the ad- 
ministration of 5azacytidine [7]. 
In murine erythroleukemic cells, 5azacytidine 
has been shown to be a weak inducer of 
hemoglobin synthesis [S]. Here, the addition of 
5azacytidine to DMSO- or butyric acid-induced 
cells increased the amount of hemoglobin 
translated. By adding hemin the quantity of 
hemoglobin and globin was increased in 
5-azacytidine-treated cells suggesting that there 
was additional globin and messenger RNA in the 
cell. The findings suggested, but not conclusively, 
Erythroleukemic cell 
5-Azacytidine 
Electrophoresis 
that the 5-azacytidine is demethylating the DNA 
resulting in an increased embryonic globin gene 
expression. 
2. MATERIALS AND METHODS 
2.1. Growth and induction of Friend-erythro- 
leukemic cells 
Friend-erythroleukemic cells (T3C12) derived 
from a DDD mouse were obtained from the Mam- 
malian Genetics Mutant Cell Repository at the In- 
stitute of Medical Research (Camden NJ; classified 
as GM979). The cells are grown in suspension in a 
humidified tissue culture incubator containing 5% 
CO2 at 37°C. Alpha-medium supplemented with 
10% fetal calf serum and antibiotics-antimycotics 
is used to support cell growth. The cells are main- 
tained in continuous log phase culture between 5 x 
lo4 cells/ml and 1 x IO6 cells/ml. Optimum condi- 
tions for the induction of differentiation in the 
MELC system occur with the addition of 1.5% 
DMSO or 1 mM butyric acid (BA). To prepare a 
sufficient quantity of hemoglobin or globin, 
20 mM HEPES is added to a-medium containing 
10% fetal calf serum, and the cells are grown in 
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spinner culture flasks. The cells are washed 3-times 
and lysed as follows. 
Hemoglobin was obtained by washing the 
erythrocytes 3-limes in phosphate-buffered saline 
followed by lysing the cells by adding 3 volumes of 
lysing medium for 15 min at 4°C (0.5% Triton 
X-100, 25 mM Tris-HCl, 25 mM KCl, 5 mM 
MgC12, 1 mM 2-mercaptoethanol, 20 mM KCN) 
[9]. The KCN was freshly made and added to lys- 
ing buffer prior to use. Cell debris was then remov- 
ed by centrifugation at 20000 x g for 20 min and 
the supernatant solution containing hemoglobin 
was stored at - 70°C 191. 
2.2. Cell volume and cell growth 
The electronic cell volume is measured on a 
Coulter Hq Channelyzer and the electronic cell 
count is made simultaneously on a Coulter 
Counter, Model ZBI equipped with an aperture 
tube containing a 70-pm diameter and 84-pm 
length orifice on the aperture tube (Coulter Elec- 
tronics, Hialeah FL). To obtain reproducible 
results for electronic cell volume analysis and 
counting, the tissue culture cells are removed from 
culture, dispersed, and immediately fixed with an 
equal volume of filtered glutaraldehyde in 
phosphate-buffered saline resulting in a final fixa- 
tion concentration of 3% glutaraldehyde. Due to 
cell shape factors, mouse fetal blood cells can be 
counted and sized without prior fixing. 
2.3. Chemicals 
A lo-mM solution of hemin is made by dissolv- 
ing 13 mg in 0.2 ml 0.5 M NaOH buffered with 
0.25 ml 1 M Tris-HCl (pH 7.8) and subsequently 
diluting the solution to 2 ml with H20. The stock 
solution is then sterilized by filtration, stored at 
- 70°C and used at 10M4 for experiments [lo]. 
DMSO (Pierce) is added to cultures directly. 
Butyric acid (100 mM) is dissolved in H20, steriliz- 
ed by filtration, stored at 4”C, and used at a con- 
centration of 1 mM. 
2.4. Isoelectric focusing 
Analytical and preparative isoelectric focusing 
(IEF) is performed in 3 mm (inside diameter) tubes 
using 4% polyacrylamide gels containing 2% am- 
pholines of the following ranges: 6-8 (50%), 
8-9.5 (33%), 9.5-11 (17%) [11,12]. The tube gels 
are then prefocused at 0.2 W/gel for 0.5 h after 
which the samples are layered on the gel. Isoelec- 
tric focusing conditions consist of a constant 
0.2 W/gel at a temperature of 4°C for 2.5-3 h. 
The bands are sliced out, eluted with Hz0 and the 
eluent lyophilized for globin analysis [12]. To im- 
prove the analytical IEF resolution, we use an LKB 
multiphore unit with thin slab-type gels (0.4 mM) 
to separate hemoglobins (the gel is prepared using 
3 sheets of parafilm gasketing to obtain a 0.4 mM 
spacing and a Gelbond plastic molding sheet, 
LKB). The slab gels are prefocused for 0.5 h at 
10 W, after which the samples (0.5 ~1-2 /cl) are ap- 
plied as a drop to the gel surface and then elec- 
trophoresed for and run for 1.5 h at 4°C. 
The standard procedure in preparing hemo- 
globin for tube gel IEF is to add between lo-50 /cl 
of this solution to the 3 mm polyacrylamide disc 
gels to achieve a hemoglobin concentration 
suitable for globin analysis of liquid scintillation 
counting. For analytical IEF (slab gels) 2 ,~l of 
hemoglobin are added to the cathode region of the 
gel. If there is low intensity in the hemoglobin 
bands the analytical gels are stained with 0.1% 3-3 
dimethoxybenzidine hydrochloride dissolved in 
1% acetic acid. About 10 ~1 30% H202/10 ml are 
added to stain the hemoglobin bands. This is 
followed by photography and 10 W are applied for 
1.5 h after which the gel is fixed in 5% trichloro- 
acetic acid, 5% sulfosalicylic acid, 20% MeOH 
with 0.1% filtered Coomassie blue. The gels are 
processed for fluorography with Enhance (New 
England Nuclear), dried down and exposed to 
Kodak X-ray film XAR-5 for l-3 days depending 
on the level of t3H]leucine incorporation [13]. 
2.5. Gel electrophoresis of globins 
Globin chains are separated by 0.75 mm thick 
slab gel electrophoresis (Bio Rad Model 220) on 
9% polyacrylamide containing 6 M urea, 2% 
Triton X-100 in 5% acetic acid as in [14] and as 
modified in [ 151. The gel is pre-electrophoresed for 
30 min at 200 V at 4°C. Then 50~1 of 1 M & 
mercaptoethylamine is added to each sample well, 
and a second pre-electrophoresis made at 150 V 
for 30 min at 4°C. The &mercaptoethylamine is 
removed and the lyophilized hemoglobins eluted 
from IEF gels or the unseparated hemoglobins are 
suspended into 20~1 of sample buffer (5 ml of 
freshly deionized 8 M urea, 0.5 ml glacial acetic 
acid, 0.5 ml 2-mercaptoethanol) and layered in 
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each well. The samples are electrophoresed for 
3.5 h at 20 mA. The gel is fixed in a solution con- 
taining 3.5% sulfosalicylic acid, 11.4% 
trichloroacetic acid in Hz0 for 0.5 h. The defixing, 
staining and destaining steps are carried out in 
30070 ETOH and 10% acetic acid. The gel is defix- 
ed for 0.5 h, stained with 0.1% Coomassie blue 
overnight and destained until the bands can be 
photographed. The gel is prepared for 
fluorography by treatment with Enhance (New 
England Nuclear), followed by drying the gel onto 
a filter paper. The gels are exposed to Kodak 
XAR-5 X-ray film for 3-7 days depending on the 
level of 3H-incorporation and developed using 
Kodak X-ray developer for 5 min [13]. 
3. RESULTS AND DISCUSSION 
T3C12 murine erythroleukemic cells have been 
shown to express both embryonic, adult 
hemoglobins [6,17]. The addition of 5-azacytidine 
(0.5 mm) to BA (1 mm)- or DMSO (1.5%)- 
induced cells resulted in altered hemoglobin gene 
expression, The T3C12 cells were induced to dif- 
ferentiate with BA or DMSO and at day 1 and/or 
day 2, 5-azacytidine was added to cultures. 
5Azacytidine had little effect on the growth of 
DMSO-induced cells while it reduced the growth of 
BA-induced cells by 50% (fig.1). The hemoglobins 
obtained from the induced cells between 3 and 5 
days were separated and analyzed by 3 elec- 
trophoresis techniques: (i) isoelectric focusing slab 
gels (0.4 mm) with fluorography; (ii) isoelectric 
focusing tube gels (3 mm) for scintillation counts; 
(iii) acid-urea Triton X-100 slab gels (75 mm) for 
globin analysis. Analytical isoelectric focusing of 
hemoglobins derived from BA- or DMSO-treated 
cells showed that 5-azacytidine increased the syn- 
thesis of E2 and A in DMSO-treated cells (fig.2A) 
and increased the synthesis of band 1, E2 and A in 
BA-induced cells. The globin consistency of these 
bands has been established to be the following: 
band 6 (&z), band 4 (a&, band 1 (a&. 
Previous data from our laboratory have shown an 
increased hemoglobin stimulation when hemin is 
added to MELC, which were induced to differen- 
tiate. In both BA- and DMSO-induced cells treated 
with 5-azacytidine, the synthesis of A and Ez bands 
were greatly increased after hemin was added to 
the cultures. The data suggest hat the level of un- 
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Fig.1. Growth of BA- and DMSO-induced cells in the 
presence of 5azacytidine. MEL were induced with BA 
(1 mM) or DMSO (1.5%) and on days 1 and 2, 0.5 pM 
5-azacytidine was added. The cells were monitored for 
growth and cell volume using a Coulter channelizer. The 
cell volume of the 5-azacytidine-treated cells was larger 
than the control cells. (o--o) DMSO; (A---A) 
DMSO + S-AZ; (A-4) BA; (o---o) BA + S-AZ. 
translated mRNA was greater in DMSO-induced 
cells which were treated with 5azacytidine than the 
level in DMSO cells which were not treated with 
5azacytidine. 
In order to determine the relative rate of syn- 
thesis of the tissue culture-derived hemoglobins, 
3-mm tube gels were used with the isoelectric 
focusing method to separate the hemoglobins. The 
hemoglobins of band 6 (A) and band 4 (Ez), which 
were visible were cut and eluted overnight from the 
gels in 1OOJ HzO. Band 1 was not obtained as it 
was not usually visible unless the gels were stained 
with benzidine. As shown in table 1, the addition 
of 5-azacytidine increased the synthesis of 
hemoglobin in both DMSO- and BA-induced 
samples. The addition of hemin also increased the 
synthesis of the A and E2 bands in both control 
and 5-azacytidine-treated cells. The addition of 
5-azacytidine to 48-h DMSO-treated cells resulted 
in an increase in globin synthesis when assayed 
with hemin at 96 h (fig.3). The data correlate with 
fig.2A, showing that in addition to more 
hemoglobin, hemin synthesized more globin. 
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Fig.2. Fluorogram of hemoglobins derived from DMSO- 
stimulate (A) or BA-stimulated (B) cells. The cells were 
washed and lysed with a fixed volume of Iysing solution 
and 2 pl were layered on 0.4 mM thin gel. S-Azacytidine 
(S-AZ, 0.5 FM) was added on days 1 and 2 of culture and 
hemin (1OOpM) was added on day 5 of culture at the 
time of labeling. Fluorograms were incubated for 3 days 
at - 70°C. In (A) all the samples have the same quantity 
of hemoglobin while in (B) the 5-azacytidine samples 
had half the amount of cells of control cells (A,C). 
The effect of 5-azacytidine on the differentiation 
of MEL cells can occur at the level of globin 
transcription or heme synthesis. Previous studies 
have shown that 5-azacytidine is an inducer of 
Fig.3. Fluorogram of globins derived from the DMSO- 
stimulated cells treated with 5-azacytidine (1rM) at 48 h 
and hemin 100 &I for 4 h at the time of labeling (% h). 
The data show the increase of cy-, @ and y-globins in the 
5-azacytidine sample relative to the control. The 
addition of hemin will increase the synthesis of the czr- 
and Bglobins if the messenger is present. The 
hemoglobin lysate (20~1) was mixed with 20~1 
denaturing buffer and layered onto an acid-urea Triton 
X-100 gel. Electrophoresis lasted for 3.5 h at 20 MA, 
after which the gel was fixed, stained, enhanced and 
incubated at - 70°C for 10 days. 
MELC and selectively stimulates embryonic 
globins in human ~-th~~semia and sickle cell 
anemia patients [7). The addition of hemin to 
5-azacytidine-treated cells showed a greater syn- 
thesis of hemoglobins and globins than in control 
cells. This suggests that 5-azacytidine increases the 
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Experiment Band 6 Band 4 
DMSO + ~-AZ DMSO + ~-AZ + hemin DMSO + ~-AZ + hemin 
DMSO DMSO + hemin DMSO + ~-AZ 
lo3 cells IO3 cells Band 6 Band 4 Band 6 Band 4 Band 6 Band 4 
(cpm) (cpm) 
DMSO 7.1 3.4 
+ ~-AZ 11.0 7.2 1.54 2.11 0.5 0.86 2.09 1.65 
+ hemin 46 14 
+ ~-AZ + hemin 23 12 
BA 3.1 6.3 
+ ~-AZ 6.6 13.2 2.13 2.09 4.03 1.52 12.86 2.64 
+ hemin 21.0 23.0 
+ ~-AZ + hemin 84.0 35.0 
DMSO 5.2 1.9 
+ ~-AZ 16.0 8.0 3.09 4.27 1.42 2.71 7.52 2.56 
+ hemin 28.9 4.8 
+ ~-AZ + hemin 41.0 13.0 
BA 3.4 2.1 
+ ~-AZ 5.2 4.6 1.53 2.25 1.23 1.29 3.91 1.21 
+ hemin 16.6 4.4 
+ ~-AZ + hemin 20.5 5.6 
quantity of mRNA available for translation at the 
time of assay (5 days after differentiation). Thus, 
the addition of 5azacytidine and a strong inducer 
(DMSO or BA) of MEL cells increases the level of 
hemoglobin synthesis occurring in the cell. 
The T3C12 cells appear to be a good model 
system to investigate the effects on 5azacytidine- 
altered gene expression of globin genes [16]. The 
model system can be easily manipulated, better 
defined and can facilitate and supplement he in 
vivo studies of 5azacytidine on man. 
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